Concentrix Corporation (NASDAQ:CNXC) Given Consensus Rating of “Hold” by Analysts

Concentrix Corporation (NASDAQ:CNXC) has been assigned an average recommendation of “Hold” from the five ratings firms that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company. The average 1-year target price among brokers that have covered the stock in the last year is $32.75.

CNXC has been the subject of several recent analyst reports. Robert W. Baird decreased their target price on shares of Concentrix from $40.00 to $30.00 and set an “outperform” rating for the company in a report on Tuesday. Canaccord Genuity Group decreased their target price on shares of Concentrix from $55.00 to $45.00 and set a “buy” rating for the company in a report on Tuesday. Weiss Ratings reiterated a “sell (d)” rating on shares of Concentrix in a report on Monday, April 27th. Wall Street Zen cut shares of Concentrix from a “buy” rating to a “hold” rating in a report on Saturday, March 28th. Finally, Barrington Research decreased their price target on shares of Concentrix from $38.00 to $30.00 and set an “outperform” rating for the company in a report on Tuesday.

Concentrix Stock Performance

Shares of CNXC opened at $22.41 on Wednesday. Concentrix has a one year low of $19.12 and a one year high of $62.14. The company has a 50-day moving average of $25.69 and a two-hundred day moving average of $31.96. The stock has a market cap of $1.37 billion, a price-to-earnings ratio of -1.05, a PEG ratio of 0.32 and a beta of 0.44. The company has a debt-to-equity ratio of 1.43, a current ratio of 1.18 and a quick ratio of 1.18.

Concentrix (NASDAQ:CNXC) last announced its earnings results on Monday, June 29th. The company reported $2.63 EPS for the quarter, missing the consensus estimate of $2.64 by ($0.01). Concentrix had a positive return on equity of 18.93% and a negative net margin of 13.16%.The firm had revenue of $2.46 billion during the quarter, compared to analyst estimates of $2.47 billion. During the same quarter in the previous year, the business earned $2.70 earnings per share. The business’s quarterly revenue was up 1.9% compared to the same quarter last year. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. On average, equities research analysts expect that Concentrix will post 10.42 earnings per share for the current year.

Concentrix Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, August 4th. Investors of record on Friday, July 24th will be issued a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a dividend yield of 6.4%. The ex-dividend date is Friday, July 24th. Concentrix’s dividend payout ratio (DPR) is currently -6.68%.

Key Concentrix News

Here are the key news stories impacting Concentrix this week:

• Positive Sentiment: Concentrix reported record second-quarter cash flow from operations of $258 million and adjusted free cash flow of $242 million, and management said iX Suite deals rose 400% year over year, signaling progress in its AI and software-related growth efforts.
• Positive Sentiment: Several analysts still see upside despite trimming targets: Barrington Research and Robert W. Baird both reiterated outperform ratings while cutting price targets to $30, and Canaccord Genuity kept a bullish stance even after lowering its forecast.
• Neutral Sentiment: The company declared a quarterly dividend of $0.36 per share, which implies a 5.7% annualized yield and may help support investor interest.
• Negative Sentiment: Q2 adjusted EPS of $2.63 missed the $2.64 consensus estimate, and revenue of $2.46 billion came in slightly below expectations, reinforcing concerns that growth is slowing.
• Negative Sentiment: Management also cut FY2026 and Q3 guidance below Wall Street forecasts, citing clients trimming spend; that downgrade to the outlook is the main reason the stock is under pressure.
• Negative Sentiment: Analysts and market commentary pointed to margin pressure, weaker cash generation in some measures, and leverage concerns, which are adding to the selloff in CNXC shares.

Insider Activity at Concentrix

In related news, CFO Andre S. Valentine purchased 2,500 shares of the firm’s stock in a transaction that occurred on Thursday, April 9th. The stock was acquired at an average cost of $27.95 per share, for a total transaction of $69,875.00. Following the completion of the acquisition, the chief financial officer owned 89,066 shares in the company, valued at $2,489,394.70. This trade represents a 2.89% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 29th. The stock was sold at an average price of $22.25, for a total transaction of $133,500,000.00. Following the sale, the insider owned 2,773,667 shares of the company’s stock, valued at approximately $61,714,090.75. This represents a 68.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 0.90% of the company’s stock.

Institutional Trading of Concentrix

Institutional investors have recently made changes to their positions in the stock. Huntington National Bank boosted its holdings in shares of Concentrix by 6,011.1% during the third quarter. Huntington National Bank now owns 550 shares of the company’s stock worth $25,000 after purchasing an additional 541 shares during the period. Larson Financial Group LLC boosted its holdings in shares of Concentrix by 224.9% during the third quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock worth $32,000 after purchasing an additional 479 shares during the period. Geneos Wealth Management Inc. raised its position in Concentrix by 532.7% during the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after acquiring an additional 522 shares in the last quarter. Global Retirement Partners LLC raised its position in Concentrix by 1,032.5% during the fourth quarter. Global Retirement Partners LLC now owns 872 shares of the company’s stock valued at $36,000 after acquiring an additional 795 shares in the last quarter. Finally, Allworth Financial LP raised its position in Concentrix by 90.6% during the third quarter. Allworth Financial LP now owns 856 shares of the company’s stock valued at $40,000 after acquiring an additional 407 shares in the last quarter. 90.34% of the stock is currently owned by institutional investors and hedge funds.

Concentrix Company Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.